Methylation of transcription factor YY2 regulates its transcriptional activity and cell proliferation

• Published in: Cell discovery Vol. 3; no. 1; p. 17035
• Main Authors: Wu, Xiao-nan, Shi, Tao-tao, He, Yao-hui, Wang, Fei-fei, Sang, Rui, Ding, Jian-cheng, Zhang, Wen-juan, Shu, Xing-yi, Shen, Hai-feng, Yi, Jia, Gao, Xiang, Liu, Wen
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 03.10.2017; Springer Nature B.V; Nature Publishing Group
• Subjects: 631/337/176; 631/337/572; Biomedical and Life Sciences; Cancer; Cell Biology; Cell Culture; Cell Cycle Analysis; Cell growth; Cell Physiology; Cell proliferation; Chromatin; CRISPR; Deoxyribonucleic acid; DNA; DNA methylation; Gene regulation; Genes; Genome editing; Immunoprecipitation; Life Sciences; Localization; Lysine; Post-translation; Ribonucleic acid; RNA; RNA editing; Stem Cells; Transcription factors; YY1 protein; SET7/9; YY2; cell proliferation; lysine methylation; LSD1
• ISSN: 2056-5968; 2056-5968
• DOI: 10.1038/celldisc.2017.35

Yin Yang 1 (YY1) is a multifunctional DNA-binding transcription factor shown to be critical in a variety of biological processes, and its activity and function have been shown to be regulated by multitude of mechanisms, which include but are not limited to post-translational modifications (PTMs), its associated proteins and cellular localization. YY2, the paralog of YY1 in mouse and human, has been proposed to function redundantly or oppositely in a context-specific manner compared with YY1. Despite its functional importance, how YY2’s DNA-binding activity and function are regulated, particularly by PTMs, remains completely unknown. Here we report the first PTM with functional characterization on YY2, namely lysine 247 monomethylation (K247me1), which was found to be dynamically regulated by SET7/9 and LSD1 both in vitro and in cultured cells. Functional study revealed that SET7/9-mediated YY2 methylation regulated its DNA-binding activity in vitro and in association with chromatin examined by chromatin immunoprecipitation coupled with sequencing (ChIP-seq) in cultured cells. Knockout of YY2, SET7/9 or LSD1 by CRISPR (clustered, regularly interspaced, short palindromic repeats)/Cas9-mediated gene editing followed by RNA sequencing (RNA-seq) revealed that a subset of genes was positively regulated by YY2 and SET7/9, but negatively regulated by LSD1, which were enriched with genes involved in cell proliferation regulation. Importantly, YY2-regulated gene transcription, cell proliferation and tumor growth were dependent, at least partially, on YY2 K247 methylation. Finally, somatic mutations on YY2 found in cancer, which are in close proximity to K247, altered its methylation, DNA-binding activity and gene transcription it controls. Our findings revealed the first PTM with functional implications imposed on YY2 protein, and linked YY2 methylation with its biological functions.